In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.
Resources and Tools
A recent study published in Drug and Alcohol Dependence found evidence for racial/ethnic disparities in buprenorphine distribution across the United States.
In May, the New England AIDS Education Training Center (NEAETC) published a set of pages dedicated to providing information about and resources for HIV and HIV-related topics.
This technical package, a collaborative effort between CDC and NASTAD, provides a broad framework as well as evidence-informed strategies and approaches to support the planning, design, implementation, and sustainability of new and existing syringe services programs (SSPs).
This webinar describes systemic barriers faced by patients with HIV and substance use disorders, and discusses steps providers can take to decrease these barriers and support integration of behavioral health and HIV public health interventions.
Keywords: HIV, substance use